Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 4/20 | 0.39 |
| ▸ | AGXT | P21549 | 4/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | TTR | P02766 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2411686 | 0.93 | AGXT (0.38) | ERN1PTGS2IDO1AGXTCA1 | |
| SCHEMBL198803 | 0.88 | ERN1 (0.47) | ERN1PTGS2IDO1AGXTMAOB | |
| Ether SCHEMBL8429378 | 0.83 | PTGS2 (0.36) | ERN1PTGS2IDO1AGXTTDP1 | |
| SCHEMBL10735808 | 0.83 | TTR (0.42) | IDO1AGXTMAOBTTR | |
| SCHEMBL13378275 | 0.82 | IDO1 (0.52) | ERN1PTGS2IDO1AGXTMAOB | |
| SCHEMBL11313016 | 0.81 | ERN1 (0.51) | ERN1PTGS2IDO1AGXTMAOB | |
| SCHEMBL187751 | 0.80 | HRH3 (0.47) | IDO1AGXTMAOBFAAHHRH3 | |
| SCHEMBL134443 | 0.80 | IDO1 (0.46) | ERN1PTGS2IDO1AGXTMAOB | |
| SCHEMBL9456876 | 0.80 | HRH3 (0.47) | IDO1AGXTMAOBFAAHHRH3 | |
| SCHEMBL12648082 | 0.79 | AGXT (0.54) | ERN1PTGS2IDO1AGXTMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-10310634-A | — | — | None | — | — | JP | disclosed |
| EP-2516389-B1 | FLUORINATED ARYLENE-CONTAINING COMPOUNDS, METHODS, AND POLYMERS PREPARED THEREFROM | 3M INNOVATIVE PROPERTIES CO (US) | 2016-02-17 | — | — | EP | disclosed |
| US-9045400-B2 | Fluorinated aromatic bis(acyl)-containing compounds and polyesters prepared therefrom | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-06-02 | — | — | US | disclosed |
| US-8975436-B2 | Fluorinated arylene-containing compounds, methods, and polymers prepared therefrom | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2015-03-10 | — | — | US | disclosed |
| US-20140163250-A1 | FLUORINATED AROMATIC BIS(ACYL)-CONTAINING COMPOUNDS AND POLYESTERS PREPARED THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-06-12 | — | — | US | disclosed |
| US-20120252997-A1 | FLUORINATED ARYLENE-CONTAINING COMPOUNDS, METHODS, AND POLYMERS PREPARED THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY | 2012-10-04 | — | — | US | disclosed |
| US-20120252997-A1 | FLUORINATED ARYLENE-CONTAINING COMPOUNDS, METHODS, AND POLYMERS PREPARED THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY | 2012-10-04 | — | — | US | disclosed |
| US-20120071626-A1 | FLUORINATED AROMATIC BIS(ACYL)-CONTAINING COMPOUNDS AND POLYESTERS PREPARED THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY | 2012-03-22 | — | — | US | disclosed |
| US-20120071626-A1 | FLUORINATED AROMATIC BIS(ACYL)-CONTAINING COMPOUNDS AND POLYESTERS PREPARED THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY | 2012-03-22 | — | — | US | disclosed |
| WO-2011087717-A1 | FLUORINATED ARYLENE-CONTAINING COMPOUNDS, METHODS, AND POLYMERS PREPARED THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-07-21 | — | — | WO | disclosed |
| WO-2011005396-A1 | FLUORINATED AROMATIC BIS(ACYL)-CONTAINING COMPOUNDS AND POLYESTERS PREPARED THEREFROM | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2011-01-13 | — | — | WO | disclosed |
| JP-H10310634-A | PRODUCTION OF PHENOL NOVOLAC CONDENSATE | MEIWA KASEI KK | 1998-11-24 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140163250-A1 | FLUORINATED AROMATIC BIS(ACYL)-CONTAINING COMPOUNDS AND POLYESTERS PREPARED THEREFROM | NOTUM, FFAR1, FFAR2 | ERN1 3948/4885PTGS2 4777/4885IDO1 4249/4885 |
| US-20120071626-A1 | FLUORINATED AROMATIC BIS(ACYL)-CONTAINING COMPOUNDS AND POLYESTERS PREPARED THEREFROM | AFF1, AFF2, FFAR2 | ERN1 1865/4885PTGS2 3311/4885IDO1 4213/4885 |
| US-20120252997-A1 | FLUORINATED ARYLENE-CONTAINING COMPOUNDS, METHODS, AND POLYMERS PREPARED THEREFROM | WASF2, PFAS, FLI1 | ERN1 3603/4885PTGS2 3006/4885IDO1 3252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.